YAP1 and pancreatic neoplasm: The suppression of YAP/TAZ activity in in vivo studies of breast cancer, pancreatic cancer, and osteosarcoma have also demonstrated the contribution of these downstream Hippo proteins on tumorigenesis (51, 54, 55).